Deals channel feed

SPAC eu­reK­ING ac­quires an­oth­er man­u­fac­tur­er

Last year
Manufacturing

Mer­ck en­lists As­tex to search for p53 can­cer drug in ex­pand­ed deal

Last year

Gink­go Bioworks nets sec­ond con­tract with Mer­ck

Last year
Manufacturing

Ike­na inks small cash grab in all-stock deal for Pi­o­nyr to take can­cer drug on Hip­po path­way

Last year
Startups

BAR­DA or­ders more small­pox and mpox vac­cines from Bavar­i­an Nordic

Last year
Pharma
Manufacturing

De­tails emerge on Cidara/J&J in­fluen­za part­ner­ship, with a count­down on next steps

Last year
Pharma

Up­dat­ed: Seagen de­pri­or­i­tizes an­ti­body-drug can­di­date from $4.2B Mer­ck deal

Last year

Agios to take over Al­ny­lam’s pre­clin­i­cal siR­NA blood dis­or­der as­set in a deal worth $147.5M

Last year
R&D

No­var­tis, Io­n­is will work to­geth­er again in the next-gen­er­a­tion car­dio space

Last year

Bausch + Lomb CEO Brent Saun­ders search­es for small­er deals while 'di­gest­ing' $1.75B Xi­idra move

Last year

Mar­tin Shkre­li's old com­pa­nies se­cure $650,000 deal to sell Dara­prim amid bank­rupt­cy

Last year
Pharma

Pro­QR finds eye dis­ease part­ner in Eu­rope, hands off two late-stage can­di­dates

Last year
Pharma

BAR­DA awards Emer­gent 10-year, $704M con­tract for Ebo­la treat­ment

Last year
Manufacturing

TG Ther­a­peu­tics signs $645M deal to kick-start in­ter­na­tion­al launch of MS an­ti­body 

Last year

Up­dat­ed: EQRx sells it­self to an­oth­er Alex­is Borisy com­pa­ny, Rev­o­lu­tion Med­i­cines, in all-stock deal

Last year

A deal? An as­set sale? A launch? Every­one is watch­ing next moves for Roivant, Bridge­Bio

Last year
Pharma

Bio­gen makes its move, an­nounc­ing a $7.3B deal for Rea­ta

Last year

As­traZeneca picks up Pfiz­er’s rare dis­ease gene ther­a­pies, taps new R&D leader as Mene Pan­ga­los steps down

Last year
People

Ipsen ends neu­ro­tox­in pact with Gal­der­ma af­ter ar­bi­tra­tion cas­es filed in in­ter­na­tion­al court

Last year
Law

In­fin­i­ty Phar­ma­ceu­ti­cals lays off 78% of staff, shrinks board af­ter MEI merg­er fail

Last year

Gilead re­news IT con­tract with Cog­nizant in bid to more quick­ly bring drugs to mar­ket 

Last year
Pharma

Cor­rect­ed: Roche is not mov­ing for­ward with SQZ pro­gram, send­ing the biotech in­to strate­gic re­view

Last year

Astel­las en­lists Pep­tiDream in search for pro­tein de­graders as it looks to act fast in hot field

Last year

Te­va and Alvotech strike deal for 'in­creased in­volve­men­t' at Alvotech's trou­bled Ice­land site

Last year
Pharma
First page Previous page 29303132333435 Next page Last page
A service from the Financial Times